...
首页> 外文期刊>International Journal of Applied and Basic Medical Research >Feasibility of bisphosphonate therapy in an Indian pediatric patient of fibrodysplasia ossificans progressiva
【24h】

Feasibility of bisphosphonate therapy in an Indian pediatric patient of fibrodysplasia ossificans progressiva

机译:双膦酸盐治疗在印度小儿骨化性纤维增生症患者中的可行性

获取原文
           

摘要

Fibrodysplasia ossificans progressiva, also known as myositis ossificans progressiva, is a rare autosomal dominant disorder (1 in 2 million). It produces a catastrophic and crippling illness in young people for which there is no effective treatment. This case report presents a case of 7-year-old child misdiagnosed as osteogenesis imperfecta admitted with severe disability and pain. He was diagnosed by clinical and radiological methods, treated with bisphosphonates for pain relief along with calcium and Vitamin D, and followed till 4 years.
机译:骨化性纤维增生症,也称为骨化性肌炎,是一种罕见的常染色体显性遗传疾病(百万分之一)。如果没有有效的治疗方法,它会在年轻人中造成严重的灾难性疾病。该病例报告介绍了一个被误诊为成骨不全症的7岁儿童,患有严重的残疾和疼痛。通过临床和放射学方法对他进行了诊断,用双膦酸盐,钙和维生素D缓解疼痛,并随访4年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号